Quarterly report [Sections 13 or 15(d)]

Unaudited Condensed Consolidated Balance Sheets

v3.25.3
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2025
Jan. 31, 2025
Current assets:    
Cash and cash equivalents $ 74,569 $ 100,766
Restricted cash 2,967 2,571
Accounts receivable, net of allowance for credit losses of approximately $376 and $501 as of October 31, 2025 and January 31, 2025, respectively 103,907 178,989
Prepaid expenses and other current assets 49,213 50,527
Total current assets 230,656 332,853
Goodwill 296,300 317,071
Intangible assets, net 346,745 427,221
Other assets 23,881 28,924
Total assets 897,582 1,106,069
Current liabilities:    
Current maturities of long-term debt 6,404 6,404
Borrowings under accounts receivable facility 1,000 1,000
Accounts payable 20,920 13,458
Accrued compensation 28,546 47,803
Accrued expenses and other current liabilities 19,769 26,022
Deferred revenue 196,355 282,295
Total current liabilities 272,994 376,982
Long-term debt 570,181 573,267
Deferred tax liabilities 37,390 42,039
Deferred revenue - non-current 820 1,656
Other long-term liabilities 12,209 18,279
Total long-term liabilities 620,600 635,241
Commitments and contingencies
Shareholders’ equity (deficit):    
Shareholders’ common stock - Class A common shares, $0.0001 par value: 18,750,000 shares authorized and 9,051,822 shares issued and 8,752,045 shares outstanding as of October 31, 2025, and 8,616,633 shares issued and 8,316,856 shares outstanding as of January 31, 2025 1 1
Additional paid-in capital 1,575,259 1,565,040
Accumulated (deficit) (1,546,502) (1,443,386)
Treasury stock, at cost - 299,777 shares as of October 31, 2025 and January 31, 2025 (10,891) (10,891)
Accumulated other comprehensive income (loss) (13,879) (16,918)
Total shareholders’ equity (deficit) 3,988 93,846
Total liabilities and shareholders’ equity (deficit) $ 897,582 $ 1,106,069